Related Experiment Video
Updated: Apr 16, 2026

07:50
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
2.6K
Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step
Feng Yang1, Moses M Njire1, Jia Liu1
1State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
Plos One
|March 12, 2015
Summary
New research introduces stable, autoluminescent Mycobacterium tuberculosis reporter strains, improving drug and vaccine evaluation. These marker-free strains overcome limitations of previous versions for tuberculosis research.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Autoluminescent Mycobacterium tuberculosis reporter strains offer efficient evaluation of tuberculosis drugs and vaccines in vivo.
- Previous strains exhibited instability and reporter loss without selection.
- Kanamycin selection markers limited utility for tuberculosis drug screening and combination therapy evaluation due to resistance to essential drugs.
Purpose of the Study:
- To develop selectable marker-free and more stable autoluminescent mycobacterial reporter strains.
- To overcome limitations associated with selection markers in mycobacterial genetic manipulation.
- To create versatile reporter strains for diverse applications in tuberculosis research.
Main Methods:
- Utilized an integrative vector strategy for strain construction.
- Employed Xer site-specific recombination to remove resistance marker and integrase genes in a single step.
- Developed corresponding plasmid vectors for constructing other marker-free reporter strains.
Main Results:
- Successfully created stable, autoluminescent mycobacterial strains lacking selectable markers.
- Demonstrated the removal of resistance marker and integrase genes via Xer recombination.
- Developed convenient plasmid vectors for generating diverse marker-free reporter mycobacteria.
Conclusions:
- The developed selectable marker-free strains offer enhanced stability and broader utility for tuberculosis research.
- The integrative vector and Xer recombination strategy provides an efficient method for creating marker-free mycobacteria.
- The plasmid vectors are valuable tools for constructing novel reporter strains with various applications.

